Concepedia

Gemma Salvadó

GS

Statistics

Publications

63

Citations

5.6K

H-Index

36

Active since

2019

Affiliations

University College London(Current)

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine

Universitat Pompeu Fabra

Pasqual Maragall Foundation

Hospital Del Mar

Gemma Salvadó is an author at University College London specializing in neuroscience, alzheimer disease, and dementia.

ORCID

Publications per year

2019–2025

63

Publications

63

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum

Andréa Lessa Benedet, Marta Milà‐Alomà, Agathe Vrillon et al. · JAMA Neurology · 2021 · 631 citations · Full text

, , +17

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected

Marc Suárez‐Calvet, Thomas K. Karikari, Juan Lantero‐Rodriguez et al. · EMBO Molecular Medicine · 2020 · 414 citations · Full text

, , +17

Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests

Nicolas R Barthélemy, Gemma Salvadó, Suzanne E. Schindler et al. · Nature Medicine · 2024 · 408 citations · Full text

, , +17

Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease

Marta Milà‐Alomà, Nicholas J. Ashton, Mahnaz Shekari et al. · Nature Medicine · 2022 · 349 citations · Full text

, , +17

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers

Niklas Mattsson, Gemma Salvadó, Nicholas J. Ashton et al. · JAMA Neurology · 2023 · 295 citations · Full text

, , +17

1–5 of 63